Protection against Omicron conferred by mRNA primary vaccine series, boosters, and prior infection.
Elizabeth T ChinDavid LeidnerLauren LamsonKimberley LucasDavid M StuddertJeremy D Goldhaber-FiebertJason R AndrewsJoshua A SalomonPublished in: medRxiv : the preprint server for health sciences (2022)
A third mRNA dose provided significant, additional protection over two doses, including among individuals with prior infection. Our findings suggest that vaccination should remain a priority-even in settings with high levels of transmission and prior infection.
Keyphrases